Trader consensus on Polymarket reflects an 88.5% implied probability against the CDC issuing a new Level 4 "Do Not Travel" warning by December 31, driven by stable global public health surveillance data showing no escalating outbreaks meeting the threshold for such extreme advisories. Recent CDC and WHO updates confirm ongoing Level 4 notices remain limited to chronic hotspots like clade I mpox in the Democratic Republic of Congo and polio in select African nations, with no new destinations elevated in the past month amid declining mpox cases outside Africa and contained U.S. measles clusters at Level 2. Avian influenza H5N1 surveillance reports low human transmission risk despite dairy cow detections, while routine respiratory viruses enter seasonal norms without pandemic signals. Traders anticipate upcoming CDC briefings and WHO epidemiological reviews through year-end will sustain this low-threat posture, barring unforeseen surges.
基于Polymarket数据的AI实验性摘要 · 更新于是
NEW
NEW
Dec 31, 2026
是
NEW
NEW
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects an 88.5% implied probability against the CDC issuing a new Level 4 "Do Not Travel" warning by December 31, driven by stable global public health surveillance data showing no escalating outbreaks meeting the threshold for such extreme advisories. Recent CDC and WHO updates confirm ongoing Level 4 notices remain limited to chronic hotspots like clade I mpox in the Democratic Republic of Congo and polio in select African nations, with no new destinations elevated in the past month amid declining mpox cases outside Africa and contained U.S. measles clusters at Level 2. Avian influenza H5N1 surveillance reports low human transmission risk despite dairy cow detections, while routine respiratory viruses enter seasonal norms without pandemic signals. Traders anticipate upcoming CDC briefings and WHO epidemiological reviews through year-end will sustain this low-threat posture, barring unforeseen surges.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
市场开放时间： Jan 19, 2026, 3:15 PM ET
交易量
$0结束日期
Dec 31, 2026市场开放时间
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects an 88.5% implied probability against the CDC issuing a new Level 4 "Do Not Travel" warning by December 31, driven by stable global public health surveillance data showing no escalating outbreaks meeting the threshold for such extreme advisories. Recent CDC and WHO updates confirm ongoing Level 4 notices remain limited to chronic hotspots like clade I mpox in the Democratic Republic of Congo and polio in select African nations, with no new destinations elevated in the past month amid declining mpox cases outside Africa and contained U.S. measles clusters at Level 2. Avian influenza H5N1 surveillance reports low human transmission risk despite dairy cow detections, while routine respiratory viruses enter seasonal norms without pandemic signals. Traders anticipate upcoming CDC briefings and WHO epidemiological reviews through year-end will sustain this low-threat posture, barring unforeseen surges.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
交易量
$0结束日期
Dec 31, 2026市场开放时间
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects an 88.5% implied probability against the CDC issuing a new Level 4 "Do Not Travel" warning by December 31, driven by stable global public health surveillance data showing no escalating outbreaks meeting the threshold for such extreme advisories. Recent CDC and WHO updates confirm ongoing Level 4 notices remain limited to chronic hotspots like clade I mpox in the Democratic Republic of Congo and polio in select African nations, with no new destinations elevated in the past month amid declining mpox cases outside Africa and contained U.S. measles clusters at Level 2. Avian influenza H5N1 surveillance reports low human transmission risk despite dairy cow detections, while routine respiratory viruses enter seasonal norms without pandemic signals. Traders anticipate upcoming CDC briefings and WHO epidemiological reviews through year-end will sustain this low-threat posture, barring unforeseen surges.
基于Polymarket数据的AI实验性摘要 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题